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ABSTRACT: Leishmania, an intracellular protozoan parasite, is endemic, widespread and represents a public health 
problem in most countries of the Mediterranean basin as it is implicated in a wide spectrum of diseases both in 
humans and animals. Vaccination of canines remains the best control strategy to counteract the progression of 
active infection for canine disease in areas of the world where transmission to humans is primarily zoonotic. This 
case report describes the history of a four-year-old dog vaccinated against canine leishmaniosis that was presented 
to a private clinic for the onset of a nodular skin lesion. Besides normal haematological and biochemical analyses, 
the histopathological examination of the removed skin lesion revealed the presence of Leishmania amastigotes. 
The presence of the protozoa in the skin lesion of a vaccinated dog is discussed.
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Case description
This report describes a case of an atypical form 
of canine leishmaniosis observed in a 4-year-old 
male Boxer dog with a history of regular vaccina-
tion course against Leishmania infantum (LiESP/
QA-21, CaniLeish®, Virbac France). The complete 
primary vaccination course of three injections 
started when the dog was 18 months old, subse-
quently continuing with an annual booster vacci-
nation.
The owner brought the animal to a private vet-
erinary clinic (April 2015) for the appearance of a 
cutaneous nodule on its head (the parietal area) 
that had started to grow over the preceding three 
months. The booster vaccine dose had been ad-
ministered seven months previously. Physical ex-
amination revealed that the dog was in good health 
condition, alert, hydrated, afebrile and without 
other systemic signs, including local or peripheral 
lymphadenopathy.
The nodular skin lesion had the appearance of a 
“cabbage” excrescence with a “chickpea” diameter 
(about 1 cm); it was not ulcerated, and seemed to 
be the sole manifestation of the skin disease.
Initially, the differential diagnosis of the lesion 
included skin tumours (histiocytomas, mast cell 
tumours, cutaneous lymphoma), infectious and 
sterile granulomas, eosinophilic granulomas, cuta-
neous cysts (Ferrer et al. 1990; Koutinas et al. 1992), 
cutaneous abscesses, subcutaneous helmintho-
sis caused by Dirofilaria repens and mycetomas 
(Blavier et al. 2001). Under an appropriate sedation, 
the nodular lesion was removed, and histopatho-
logical examination revealed follicular keratosis 
and a severe and chronic inflammatory infiltrate. 
The latter, localised particularly near the skin 
annexes, was composed of many histiocytes and 
plasma cells, a moderate number of mature lym-
phocytes, a few eosinophils and rare neutrophils, 
and detectable leishmanial amastigote (2–3 µm in 
diameter) forms in the macrophages (Figure 1).
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After histopathological diagnosis, serum bio-
chemical analysis was performed and the total titres 
of anti-Leishmania antibodies were determined us-
ing an indirect immunofluorescence antibody test 
(IFAT) (MegaFLUO® LEISH; Megacor Diagnostik 
Gmbh).
The IFAT provided a negative result (titre of 
1 : 40; positive test result is ≥ 50) and the complete 
blood count (by ADVIA 2120 V automated counter) 
revealed a normal haematological profile (Table 1; 
first blood sample = 1st BS). The serum biochemical 
indicators (by Architect c8000 Clinical Chemistry 
Analyzer, Abbott Diagnostics, USA), reported in 
Table 1 (1st BS), revealed a normal pherogram pro-
file and serum protein levels as well as a moderate 
increase in alanine aminotransferase. For this rea-
son, the dog was not treated against Leishmania, 
and eight months after the diagnosis (December 
2015), the dog was still in good body condition at 
the physical examination, with blood and serum 
parameters within the physiological range (Table 1; 
second blood sample = 2nd BS). The IFAT again 
provided a negative result (titre of 1 : 40).
DISCUSSION AND CONCLUSIONS
Leishmania is an intracellular protozoan para-
site that is endemic, widespread and represents 
a public health problem in most countries of the 
Mediterranean basin as it is implicated in a wide 
spectrum of diseases both in humans and animals. 
Leishmaniosis currently threatens 350 million people 
in 98 countries, with 1.2 million new cases per year 
(Handler et al. 2015; Kahime et al. 2015). In regions 
where L. infantum is endemic, canine seropreva-
lence ranges from 5% to 37% (Alvar et al. 2004), with 
dogs also playing an important epidemiological role 
as a reservoir of infection for humans (Viegas et al. 
2012). After inoculation by the sand fly, the parasites 
disseminate towards the lymph nodes, bone marrow 
and viscera, such as the spleen and liver, where they 
replicate, causing disease. Depending on the ability 
of the host’s immune response to control parasite 
replication, the infection in dogs could range from 
subclinical/asymptomatic to fully developed disease 
(Alexandre-Pires et al. 2010). Skin lesions caused 
by Leishmania have been well-described but the 
nodular form of canine leishmaniosis is much less 
frequent (Blavier et al. 2001).
According to some authors (Ferrer et al. 1988; 
Vidor et al. 1991; Amara et al. 2000), the nodular 
form of leishmaniosis is more commonly diagnosed 
in boxers that, together with the Shepherd dogs, 
seem to be the breeds more predisposed to overt 
disease (Paltrinieri et al. 2010). Two cases of atypi-
cal nodular forms, one in the interdigital space, 
Table 1. Serum haematological profile evaluated in a 
4-year-old male dog at the first clinical examination – 
1st blood sampling (BS), and after eight months – 2nd BS
Parameter 1st BS 2nd BS Range
RBC (106/µl) 8.16 9.18 5.8–8.8
WBC (103/µl) 10.9 10.8 5.5–15.5
PLT (103/µl) 199 163 150–500
Urea (mmol/l) 14.81 16 6.43–19.6
Creatinine (µmol/l) 83.1 98.1 70.7–123.8
Glucose (mmol/l) 6.6 5.01 3.3–6.05
Fructosamine (µmol/l) 338 349 160–350
AST (IU/l) 29 37 15–40
ALT (IU/l) 72 83 15–55
Protein (g/l) 66.7 72.2 56–78
Albumin (g/l) 36.1 39.8 26.3–45.3
α1-globulin (g/l) 3.3 3.6 1.9–3.4
α2-globulin (g/l) 9.3 10.7 9–16.1
β1-globulin (g/l) 4.7 4.7 2.7–10.2
β2-globulin (g/l) 6.1 6.3 3.4–8.7
γ-globulin (g/l) 7.2 7.1 3–7.8
Albumin/globulin (ratio) 1.17 1.22 0.6–1.41
PLT = platelets, RBC = red blood cells, WBC = white blood 
cells
Figure 1. Skin, within the cytoplasm of a macrophage and 
between inflammatory cells numerous 2–4 µm, ovoid, 
protozoan amastigotes are visible (× 100 magnification)
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canine disease in areas of the world where trans-
mission to humans is primarily zoonotic (Dye 1996; 
Alvar et al. 2004). This field case further supports 
that hypothesis. Furthermore, if the immune system 
directly controls the parasite’s replication making 
the infected dogs less infectious to same sand flies 
(Bongiorno et al. 2013), this in turn could further 
reduce the number of dogs infected by sand flies 
(Moreno et al. 2014).
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and the other in the right axilla were reported by 
Ferrer et al. (1990) in dogs that were not vaccinated. 
These nodules, as the one described here, were not 
ulcerated. Other reports of atypical nodular lesions 
caused by Leishmania have been reported on a dog 
tongue (Blavier et al. 2001; Viegas et al. 2012). All 
these animals, however, also showed other findings 
attributable to leishmaniosis (i.e. positive serology 
or the presence of Leishmania in the bone mar-
row). Although in our presented case it was not 
possible to exclude dissemination to the bone mar-
row through cytological or PCR tests (the owner 
did not consent to these further investigations), a 
seroconversion was neither observed at the first 
visit nor eight months later.
Although the nodular lesion observed in the pre-
sent boxer dog could be attributable to Leishmania 
as the causative agent, it was not an atypical clinical 
manifestation of disseminated infection. Rather, it 
stemmed from a strong non-suppurative inflam-
matory reaction to the entrance of the Leishmania 
protozoa at the bite site of sand flies, in an immune-
competent animal.
The vaccine that is administered to dogs acts by 
developing long-lasting cell-mediated immune re-
sponses against L. infantum, specifically with a domi-
nant CD4+ Th1 influence in an overall mixed cellular 
response. Among all the activated inflammatory cells, 
macrophages show a strong ability to reduce the levels 
of intracellular parasites through the induction of in-
ducible nitric oxide synthase and production of nitric 
oxide derivatives (Moreno et al. 2014). This vaccine, 
recently licensed in Europe, displayed 68% to 92% 
efficacy in protecting animals against the appearance 
of clinical signs, under field conditions (Otranto and 
Dantas-Torres 2013; Oliva et 2014).
In this case, even if the vaccination was not able to 
prevent the entrance of the protozoa into the dog, 
it seems it allowed the animal to effectively control 
the infection and remain healthy. This hypothesis is 
supported by the absence of any clinical, serologi-
cal and haematological symptoms other than the 
observed nodular lesion, both at the moment of 
the physical examination and eight months later. 
Based on its histopathological features, the skin 
lesion could represent the result of a local reaction 
mediated by the cellular immune response against 
the attempt of protozoa to enter and disseminate 
in the dog.
Vaccination remains the best control strategy to 
counteract the progression of active infection for 
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